Literature DB >> 31571202

Evaluating empowerment in genetic counseling using patient-reported outcomes.

Jeanette Yuen1, Suat Y Lee1, Eliza Courtney1, John Lim2, Hazel Soh1, Shao T Li1, Yanni Chen1, Marion McAllister3, Eva K Fenwick4,5, Joanne Ngeow1,6,7.   

Abstract

Data about patient reported outcomes from cancer genetics services (CGS) are lacking but are essential to guide service evaluation and improvements. We measured improvement in empowerment, following genetic counseling in Singapore using a culturally-adapted version of the Genetic Counseling Outcome Scale (GCOS-24); and sought to identify factors associated with change in empowerment. The GCOS-24 was administered to 155 patients of the CGS, at pre- and post-counseling or testing timepoints. Of which, 110 patients underwent genetic testing. Individual pre- and post-counseling responses were subjected to Rasch analysis; the scale was subsequently split into cognitive control (CC) and emotional control (EC) domains. Associations of baseline characteristics with changes in pre- and post-CC and EC scores were assessed using multiple regression analysis. Both CC and EC scores showed significant improvement following genetic counseling and testing. While all items in the CC domain of being showed increases at follow-up, aspects of EC related to alleviating negative emotions (P = .88) and hopelessness (P = .2) did not show significant improvement. Our study revealed significant improvement in empowerment in patients who have received cancer genetic counseling, while revealing a need to cultivate hope and facilitate the alleviation of negative emotions in patients during genetic counseling.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Hope; Rasch analysis; genetic counseling; genetic services; genetic testing; regression analysis

Mesh:

Year:  2019        PMID: 31571202     DOI: 10.1111/cge.13646

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  3 in total

1.  Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.

Authors:  Panagiotis A Konstantinopoulos; Barbara Norquist; Christina Lacchetti; Deborah Armstrong; Rachel N Grisham; Paul J Goodfellow; Elise C Kohn; Douglas A Levine; Joyce F Liu; Karen H Lu; Dorinda Sparacio; Christina M Annunziata
Journal:  J Clin Oncol       Date:  2020-01-27       Impact factor: 44.544

2.  "Is that something that should concern me?": a qualitative exploration of parent understanding of their child's genomic test results.

Authors:  Dana Watnick; Jacqueline A Odgis; Sabrina A Suckiel; Katie M Gallagher; Nehama Teitelman; Katherine E Donohue; Bruce D Gelb; Eimear E Kenny; Melissa P Wasserstein; Carol R Horowitz; Siobhan M Dolan; Laurie J Bauman
Journal:  HGG Adv       Date:  2021-02-03

3.  Predictive Testing for Tumor Predisposition Syndromes in Pediatric Relatives: An Asian Experience.

Authors:  Jianbang Chiang; Jeanette Yuen; Tarryn Shaw; Hui Xuan Goh; Shao-Tzu Li; Eliza Courtney; Joanne Ngeow
Journal:  Front Pediatr       Date:  2020-10-30       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.